Itoprid Xantis 50mg 40 tablets — Made in Slovakia — Free Delivery

Product description

Itoprid Xanthis is indicated for the relief of gastrointestinal symptoms of functional non-ulcer dyspepsia (chronic gastritis), namely:

• bloating;
• feeling of quick satiety;
• pain and discomfort in the upper abdomen;
• anorexia;
• heartburn;
• nausea;
• vomit.

Compound

Active ingredient: itoprid hydrochloride;

1 tablet contains 50 mg of itopride hydrochloride;

Excipients: lactose monohydrate, corn starch; croscarmellose sodium; silicon dioxide colloidal magnesium stearate.

Contraindications

Hypersensitivity to itopride hydrochloride and other components of the preparation.

Conditions in which an increase in the contractile activity of the gastrointestinal tract can be harmful, such as gastrointestinal bleeding, mechanical obstruction or perforation.

Mode of application

For adults, the recommended dose is 150 mg per day (1 tablet (50 mg) 3 times a day before meals). The indicated dose may be reduced according to the patient's age and symptoms.

During clinical studies, the duration of use of itopride hydrochloride was up to 8 weeks.

Application features

Pregnant

As a preventive measure, it is advisable to abandon the use of itopride during pregnancy.

Children

The safety of using itopride hydrochloride in children under the age of 16 has not been established.

Drivers

There is no information on the possible effect on the reaction rate, but when deciding whether to drive vehicles or work with mechanisms, it is necessary to take into account the possibility of dizziness.

Overdose

Treatment. In case of excessive overdose, it is necessary to take the usual measures for gastric lavage and carry out symptomatic treatment.

Side effects

Gastrointestinal disorders: often - abdominal pain, diarrhea infrequently - increased salivation.

From the nervous system: infrequently - dizziness, headache.

On the part of the skin and subcutaneous tissue: infrequently - rash.

Laboratory tests: infrequently - an increased level of aminotransferase, a decrease in the number of white blood cells.

Adverse reactions with spontaneous messages reported during post-marketing use. It is not possible to accurately estimate the frequency of occurrence from the available data.

On the part of the blood and lymphatic system: leukopenia, thrombocytopenia.

From the immune system: hypersensitivity, including anaphylactoid reactions.

From the endocrine system: an increased level of prolactin in the blood.

From the nervous system: dizziness, headache, tremor.

From the digestive system: diarrhea, constipation, abdominal pain, increased salivation, nausea.

From the liver and biliary tract: jaundice.

On the part of the skin and subcutaneous tissue: rash, erythema and itching.

On the part of the reproductive system and mammary glands: gynecomastia.

Interaction

With extreme caution, preparations with a narrow therapeutic index, sustained release or with an enteric coating should be used.

Antiulcer preparations such as cimetidine, ranitidine, teprenone and cetraxate do not interfere with the prokinetic effect of itopride hydrochloride.

Anticholinergic preparations can reduce the effect of itopride hydrochloride.

Storage conditions

Store at a temperature not exceeding 30 ° C in its original packaging to protect against moisture. Keep out of the reach of children.

Shelf life is 2 years.